The Coalition on Abortion/Breast Cancer, a women's group, is aiming critics against the American Cancer Society (ACS) today because women's cancer deaths rose by 409 cases in 2003, while men's cancer deaths declined by 778 cases. Last week, the ACS celebrated a small net decrease of 369 cases - allegedly the first decline in deaths from all cancers since the government began keeping national statistics 75 years ago.
The high number of Cancer deaths was kept high, due to sustained number of breast cancer, (40,400 expected in 2005 ), being therefore the second greatest cancer killer of women.
Attention is centered on the abortion-breast cancer link, the main cause of the steady number of deaths due to all cancers and which authorities failed to signal twenty years ago. The remark is made by Karen Malec, president of the Coalition on Abortion/Breast Cancer.
"In a 1986 letter to the British journal Lancet, government scientists acknowledged that 'Induced abortion before first term pregnancy increases the risk of breast cancer.' Instead of informing women, the cancer establishment chose to cover it up by using seriously flawed research to discredit the link. Now women are paying with their lives," she argues.
Although the ACS refuses to implicate abortion in any way, it makes the following revealing admission on its website:
"Much of the long-term underlying increase in (breast cancer) incidence among women is due to historical changes in reproductive patterns, such as delayed childbearing and having fewer children."
Everyone knows what caused women to change their childbearing patterns - abortion and contraceptives.
For more information, see this article: "Women's Cancer Deaths Up, Men's Deaths Down / American Cancer Society Celebrates Net Decrease / Abortion-Breast Cancer Cover Up Responsible for Women's Deaths"
The Coalition on Abortion/Breast Cancer is an international women's organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.